InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001104659-23-123689 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-12-05 2023-12-01+ AMPH Zhou Rong Senior EVP, Production Center M - OptEx $15.20 +7,830 115.9K +7% +$119.0K
DM 2023-12-05 2023-12-01+ AMPH Zhou Rong Senior EVP, Production Center S - Sale+OE $59.03 -7,830 112.4K -7% -$462.2K
DM 2023-12-05 2023-12-01+ AMPH Zhou Rong Senior EVP, Production Center M - OptEx $0.00 -7,830 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-01 M A 4,316 $14.40 116,736 D — — (F1) Includes 79 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2023.
2 Common Common Stock 2023-12-04 S D 3,514 $59.58 112,420 D — —
3 Common Common Stock 2023-12-04 M A 3,514 $16.19 115,934 D — —
4 Common Common Stock 2023-12-01 S D 4,316 $58.58 112,420 D — —
5 Derivative Employee Stock Option (right to buy) 2023-12-04 M D 3,514 $0.00 0 D $16.19 · — to 2025-06-15 3,514 Common Stock (F4) Shares subject to the option are fully vested and immediately exercisable.
6 Derivative Employee Stock Option (right to buy) 2023-12-01 M D 4,316 $0.00 0 D $14.40 · — to 2024-04-14 4,316 Common Stock (F4) Shares subject to the option are fully vested and immediately exercisable.